Table 1.
Characteristics of the disease according to the patient enrolled and risk stratification.
| Patient ID | Gender | MDS Subtype | BM Blasts | BM Fibrosis | Perypheral Cytopenias | Karyotype | Full Karyotype | IPSS Score | Risk Category |
|---|---|---|---|---|---|---|---|---|---|
| 1 | M | RCMD | <5% | NOT EVALUATED | 0/1 | GOOD | 46, XY [20] | 0 | Low |
| 2 | F | RCMD | <5% | ABSENT | 2/3 | GOOD | 46, XX [20] | 0.5 | Int-1 |
| 3 | F | RCMD | <5% | NOT EVALUATED | 2/3 | GOOD | 46, XX [20] | 0.5 | Int-1 |
| 4 | F | RA | <5% | ABSENT | 0/1 | GOOD | 46, XX [20] | 0 | Low |
| 5 | F | RCMD | <5% | ABSENT | 0/1 | GOOD | 46, XX [20] | 0 | Low |
| 6 | F | RCMD | <5% | ABSENT | 2/3 | GOOD | 46, XX [20] | 0.5 | Int-1 |
| 7 | F | RCMD | <5% | ABSENT | 2/3 | GOOD | 46, XX [20] | 0.5 | Int-1 |
| 8 | M | RAEB-2 | 5–10% | ABSENT | 0/1 | GOOD | 46, XY [20] | 0.5 | Int-1 |
| 9 | M | RA | <5% | ABSENT | 0/1 | GOOD | 46, XY [20] | 0 | Low |
| 10 | M | RA | <5% | ABSENT | 2/3 | GOOD | 46, XY [20] | 0.5 | Int-1 |
| 11 | M | MDS-U | <5% | NOT EVALUATED | 0/1 | GOOD | 46, XY [20] | 0 | Low |
| 12 | F | RA | <5% | NOT EVALUATED | 0/1 | GOOD | 46, XX [20] | 0 | Low |
| 13 | F | RCMD | <5% | ABSENT | 0/1 | GOOD | 46, XX [20] | 0 | Low |
| 14 | M | RA | <5% | ABSENT | 0/1 | GOOD | 46, XY [20] | 0 | Low |
| 15 | M | MDS-U | <5% | MF-1 | 0/1 | GOOD | 46, XY [20] | 0 | Low |
| 16 | M | MDS-U | <5% | MF-1 | 0/1 | GOOD | 46, XY [20] | 0 | Low |
| 17 | M | RAEB-1 | 5–10% | ABSENT | 0/1 | INTERMEDIATE | 47, XY, +8 [20] | Int-1 | |
| 18 | M | RA | <5% | NOT EVALUATED | 2/3 | GOOD | 46, XY [20] | 0.5 | Int-1 |
| 19 | M | RA | <5% | NOT EVALUATED | 0/1 | GOOD | 46, XY [20] | Low | |
| 20 | M | RCMD | <5% | ABSENT | 2/3 | GOOD | 46, XY [20] | 0.5 | Int-1 |
| 21 | F | RA | <5% | NOT EVALUATED | 0/1 | INTERMEDIATE | 46, XX [20] | 0.5 | Int-1 |
| 22 | M | RCMD-RS | <5% | NOT EVALUATED | 2/3 | GOOD | 46, XY [20] | 0.5 | Int-1 |
| 23 | F | RA | <5% | NOT EVALUATED | 0/1 | GOOD | 46, XX [20] | 0 | Low |
| 24 | F | RCMD | <5% | ABSENT | 0/1 | GOOD | 46, XX [20] | 0 | Int-1 |
| 25 | F | RCMD | <5% | NOT EVALUATED | 0/1 | GOOD | 46, XX [20] | 0 | Low |
| 26 | M | RA | 5–10% | NOT EVALUATED | 2/3 | GOOD | 46, XY [20] | 1 | Int-1 |
| 27 | M | RA | <5% | ABSENT | 2/3 | GOOD | 46, XY [20] | 0.5 | Int-1 |
| 28 | M | RCMD | <5% | ABSENT | 0/1 | INTERMEDIATE | 47, XY, +8 [20] | 0.5 | Int-1 |
| 29 | F | RCMD-RS | <5% | NOT EVALUATED | 0/1 | GOOD | 46, XX [20] | 0 | Low |
| 30 | M | RCMD | <5% | MF-1 | 0/1 | INTERMEDIATE | 46, XY [20] | 0.5 | Int-1 |
| 31 | F | RA | <5% | NOT EVALUATED | 0/1 | GOOD | 46, XX [20] | 0 | Low |
| 32 | M | RA | <5% | NOT EVALUATED | 0/1 | INTERMEDIATE | 46, XY [20] | 1 | Int-1 |
| 33 | F | RCMD | <5% | NOT EVALUATED | 0/1 | GOOD | 46, XX [20] | 1 | Low |
| 34 | F | MDS-U | <5% | ABSENT | 0/1 | GOOD | 46, XX [20] | 0 | Low |
| 35 | F | RA | <5% | NOT EVALUATED | 0/1 | GOOD | 46, XX [20] | 1 | Low |
| 36 | M | RCMD | <5% | ABSENT | 0/1 | GOOD | 46, XY [20] | 0 | Low |
RCMD: Refractory Cytopenia with Multilineage Dysplasia. RA: Refractory Anemia. RAEB-1: Refractory Anemia with Excess of Blasts type 1. RAEB-2: Refractory Anemia with Excess of Blasts type 2. MDS-U: Myelodysplastic Syndrome—Undefined. RS: Ringed Syderoblasts.